Oslo, Norway, April 2, 2025 – The Board of Directors of Nykode Therapeutics ASA (OSE: NYKD) hereby calls for an Extraordinary General Meeting (EGM) to be held at meeting room FORUM - Building H, Floor 0 in Gaustadalléen 21, Oslo, Norway at 14:00 CEST on April 23, 2025.
The purpose of the meeting is to elect a new Board of Directors.
The notice of the EGM is attached. All documents regarding the EGM will also be made available at the Company’s website: https://nykode.com/investors/shareholder-meetings/
For further information, please see the Company’s website or contact the Company at IR@nykode.com
This information is subject to the disclosure requirements pursuant to sections 5-12 of the Norwegian Securities Trading Act.